Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013 (2013), Article ID 369712, 9 pages
http://dx.doi.org/10.1155/2013/369712
Review Article

PDZ Domains and Viral Infection: Versatile Potentials of HPV-PDZ Interactions in relation to Malignancy

Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo 113-8655, Japan

Received 15 May 2013; Revised 9 July 2013; Accepted 31 July 2013

Academic Editor: Edouard Cantin

Copyright © 2013 Kazunori Nagasaka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. S. Moore and Y. Chang, “Why do viruses cause cancer? Highlights of the first century of human tumour virology,” Nature Reviews Cancer, vol. 10, no. 12, pp. 878–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Arbyn, X. Castellsagué, S. de sanjosé et al., “Worldwide burden of cervical cancer in 2008,” Annals of Oncology, vol. 22, no. 12, Article ID mdr015, pp. 2675–2686, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. S. Smith, L. Lindsay, B. Hoots et al., “Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update,” International Journal of Cancer, vol. 121, no. 3, pp. 621–632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Doorbar, W. Quint, L. Banks et al., “The biology and life-cycle of human papillomaviruses,” Vaccine, vol. 20, supplement 5, no. 30, pp. F55–F70, 2012. View at Google Scholar
  5. E. L. Franco, L. L. Villa, J. P. Sobrinho et al., “Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer,” Journal of Infectious Diseases, vol. 180, no. 5, pp. 1415–1423, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Münger, “The role of human papillomaviruses in human cancers,” Frontiers in Bioscience, vol. 7, pp. d641–649, 2002. View at Google Scholar · View at Scopus
  7. M. Jiang and J. Milner, “Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference,” Oncogene, vol. 21, no. 39, pp. 6041–6048, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Münger, J. R. Basile, S. Duensing et al., “Biological activities and molecular targets of the human papillomavirus E7 oncoprotein,” Oncogene, vol. 20, no. 54, pp. 7888–7898, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Mantovani and L. Banks, “The human papillomavirus E6 protein and its contribution to malignant progression,” Oncogene, vol. 20, no. 54, pp. 7874–7887, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Scheffner, J. M. Huibregtse, R. D. Vierstra, and P. M. Howley, “The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53,” Cell, vol. 75, no. 3, pp. 495–505, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Liu, J. J. Chen, Q. Gao et al., “Multiple functions of human papillomavirus type 16 E6 contribute to the immortalization of mammary epithelial cells,” Journal of Virology, vol. 73, no. 9, pp. 7297–7307, 1999. View at Google Scholar · View at Scopus
  12. M. L. Nguyen, M. M. Nguyen, D. Lee, A. E. Griep, and P. F. Lambert, “The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo,” Journal of Virology, vol. 77, no. 12, pp. 6957–6964, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. C. P. Ponting, “Evidence for PDZ domains in bacteria, yeast, and plants,” Protein Science, vol. 6, no. 2, pp. 464–468, 1997. View at Google Scholar · View at Scopus
  14. R. T. Javier and A. P. Rice, “Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses,” Journal of Virology, vol. 85, no. 22, pp. 11544–11556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. V. K. Subbaiah, C. Kranjec, M. Thomas, and L. Banks, “PDZ domains: the building blocks regulating tumorigenesis,” Biochemical Journal, vol. 439, no. 2, pp. 195–205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Bilder, “Epithelial polarity and proliferation control: links from the Drosophila neoplastictumor suppressors,” Genes and Development, vol. 18, no. 16, pp. 1909–1925, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Kiyono, A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi, “Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 21, pp. 11612–11616, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. S. S. Lee, R. S. Weiss, and R. T. Javier, “Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 13, pp. 6670–6675, 1997. View at Google Scholar · View at Scopus
  19. L. Banks, D. Pim, and M. Thomas, “Viruses and the 26S proteasome: hacking into destruction,” Trends in Biochemical Sciences, vol. 28, no. 8, pp. 452–459, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Nakagawa and J. M. Huibregtse, “Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase,” Molecular and Cellular Biology, vol. 20, no. 21, pp. 8244–8253, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. B. A. Glaunsinger, S. S. Lee, M. Thomas, L. Banks, and R. Javier, “Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins,” Oncogene, vol. 19, no. 46, pp. 5270–5280, 2000. View at Google Scholar · View at Scopus
  22. M. Thomas, P. Massimi, C. Navarro, J.-P. Borg, and L. Banks, “The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins,” Oncogene, vol. 24, no. 41, pp. 6222–6230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Lee and L. A. Laimins, “Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31,” Journal of Virology, vol. 78, no. 22, pp. 12366–12377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Doorbar, “The papillomavirus life cycle,” Journal of Clinical Virology, vol. 32, supplement 1, pp. S7–S15, 2005. View at Google Scholar
  25. M. Thomas, N. Narayan, D. Pim et al., “Human papillomaviruses, cervical cancer and cell polarity,” Oncogene, vol. 27, no. 55, pp. 7018–7030, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. E. R. Flores, B. L. Allen-Hoffmann, D. Lee, C. A. Sattler, and P. F. Lambert, “Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line,” Virology, vol. 262, no. 2, pp. 344–354, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Nicolaides, C. Davy, K. Raj, C. Kranjec, L. Banks, and J. Doorbar, “Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance,” Virology, vol. 414, no. 2, pp. 137–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Kamei, K. Kito, T. Takeuchi et al., “Human scribble accumulates in colorectal neoplasia in association with an altered distribution of β-catenin,” Human Pathology, vol. 38, no. 8, pp. 1273–1281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Zhan, A. Rosenberg, K. C. Bergami et al., “Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma,” Cell, vol. 135, no. 5, pp. 865–878, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. H. B. Pearson, P. A. Perez-Mancera, L. E. Dow et al., “SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia,” Journal of Clinical Investigation, vol. 121, no. 11, pp. 4257–4267, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Ouyang, W. Zhan, and L. Dan, “hScrib, a human homolog of Drosophila neoplastic tumor suppressor, is involved in the progress of endometrial cancer,” Oncology Research, vol. 18, no. 11-12, pp. 593–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Banks, D. Pim, and M. Thomas, “Human tumour viruses and the deregulation of cell polarity in cancer,” Nature Reviews Cancer, vol. 12, no. 12, pp. 877–886, 2012. View at Google Scholar
  33. A. L. Cavatorta, G. Fumero, D. Chouhy et al., “Differential expression of the human homologue of Drosophila discs large oncosuppressor in histologic samples from human papilloma virus-associated lesions as a marker for progression to malignancy,” International Journal of Cancer, vol. 111, no. 3, pp. 373–380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Massimi, N. Gammoh, M. Thomas, and L. Banks, “HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation,” Oncogene, vol. 23, no. 49, pp. 8033–8039, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Nakagawa, T. Yano, K. Nakagawa et al., “Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix,” British Journal of Cancer, vol. 90, no. 1, pp. 194–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Krishna Subbaiah, P. Massimi, S. S. Boon et al., “The invasive capacity of HPV transformed cells requires the hDlg-dependent enhancement of SGEF/RhoG activity,” PLOS Pathogens, vol. 8, no. 2, Article ID e1002543, 2012. View at Google Scholar
  37. P. Massimi, N. Narayan, A. Cuenda, and L. Banks, “Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation,” Oncogene, vol. 25, no. 31, pp. 4276–4285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Narayan, P. Massimi, and L. Banks, “CDK phosphorylation of the discs large tumour suppressor controls its localisation and stability,” Journal of Cell Science, vol. 122, part 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Sabio, J. S. C. Arthur, Y. Kuma et al., “p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP,” The EMBO Journal, vol. 24, no. 6, pp. 1134–1145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Branca, M. Ciotti, D. Santini et al., “Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer,” American Journal of Clinical Pathology, vol. 122, no. 6, pp. 902–911, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Nagasaka, D. Pim, P. Massimi et al., “The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction,” Oncogene, vol. 29, no. 38, pp. 5311–5321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Nagasaka, T. Seiki, A. Yamashita et al., “A novel interaction between hScrib and PP1γ downregulates ERK signaling and suppresses oncogene-induced cell transformation,” PLoS One, vol. 8, no. 1, Article ID e53752, 2013. View at Google Scholar
  43. J. Xia, H. J. Chung, C. Wihler, R. L. Huganir, and D. J. Linden, “Cerebellar long-term depression requires PKC-regulated interactions between GluR2/3 and PDZ domain-containing proteins,” Neuron, vol. 28, no. 2, pp. 499–510, 2000. View at Google Scholar · View at Scopus
  44. T. Sonoda, C. Mochizuki, T. Yamashita et al., “Binding of glutamate receptor δ2 to its scaffold protein, Delphilin, is regulated by PKA,” Biochemical and Biophysical Research Communications, vol. 350, no. 3, pp. 748–752, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Kühne, D. Gardiol, C. Guarnaccia, H. Amenitsch, and L. Banks, “Differential regulation of human papillomavirus E6 by protein kinase A: conditional degradation of human discs large protein by oncogenic E6,” Oncogene, vol. 19, no. 51, pp. 5884–5891, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. S. S. Boon and L. Banks, “High-risk human papillomavirus E6 oncoproteins interact with 14-3-3ζ in a PDZ binding motif-dependent manner,” J Virol, vol. 87, no. 3, pp. 1586–1595, 2013. View at Google Scholar
  47. D. Jackson, M. J. Hossain, D. Hickman, D. R. Perez, and R. A. Lamb, “A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4381–4386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Thomas, C. Kranjec, K. Nagasaka, G. Matlashewski, and L. Banks, “Analysis of the PDZ binding specificities of Influenza A Virus NS1 proteins,” Virology Journal, vol. 8, article 25, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Li, S. Labrecque, M. C. Gauzzi et al., “The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-α,” Oncogene, vol. 18, no. 42, pp. 5727–5737, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Senba and N. Mori, “Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection,” Oncology Reviews, vol. 6, no. 2, 2012. View at Google Scholar
  51. M. A. James, J. H. Lee, and A. J. Klingelhutz, “Human papillomavirus type 16 E6 activates NF-κB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner,” Journal of Virology, vol. 80, no. 11, pp. 5301–5307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. R. A. Watson, M. Thomas, L. Banks, and S. Roberts, “Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes,” Journal of Cell Science, vol. 116, part 24, pp. 4925–4934, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Massimi, P. Zori, S. Roberts, and L. Banks, “Differential regulation of cell-cell contact, invasion and anoikis by hScrib and hDlg in keratinocytes,” PLoS One, vol. 7, no. 7, Article ID e40279, 2012. View at Google Scholar
  54. S. Jeon and P. F. Lambert, “Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 5, pp. 1654–1658, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. M. M. R. Arkin and J. A. Wells, “Small-molecule inhibitors of protein-protein interactions: progressing towards the dream,” Nature Reviews Drug Discovery, vol. 3, no. 4, pp. 301–317, 2004. View at Google Scholar · View at Scopus
  56. K. K. Dev, “Making protein interactions druggable: targeting PDZ domains,” Nature Reviews Drug Discovery, vol. 3, no. 12, pp. 1047–1056, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Grandy, J. Shan, X. Zhang et al., “Discovery and characterization of a small molecule inhibitor of the PDZ domain of dishevelled,” Journal of Biological Chemistry, vol. 284, no. 24, pp. 16256–16263, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Shan, X. Zhang, J. Bao, R. Cassell, and J. J. Zheng, “Synthesis of potent dishevelled PDZ domain inhibitors guided by virtual screening and NMR studies,” Chemical Biology and Drug Design, vol. 79, no. 4, pp. 376–383, 2012. View at Publisher · View at Google Scholar · View at Scopus